Online inquiry

IVTScrip™ mRNA-Human ASB1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25093MR)

This product GTTS-WK25093MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASB1 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001040445.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51665
UniProt ID Q9Y576
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASB1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25093MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK21989MR IVTScrip™ mRNA-Human ARHGAP24, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP24
GTTS-WK23158MR IVTScrip™ mRNA-Human ARAP3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARAP3
GTTS-WK16721MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD36BP1
GTTS-WK22302MR IVTScrip™ mRNA-Human ARHGAP8, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARHGAP8
GTTS-WK15933MR IVTScrip™ mRNA-Human AIM1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AIM1
GTTS-WK9246MR IVTScrip™ mRNA-Human ADGRL2, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADGRL2
GTTS-WK8179MR IVTScrip™ mRNA-Human ABLIM2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABLIM2
GTTS-WK27746MR IVTScrip™ mRNA-Human ARL6, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARL6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →